Bio Roundup: A Telehealth Combo, FDA’s BCMA OK, Biogen’s Bet & More
Xconomy
AUGUST 7, 2020
The novel coronavirus has driven the pharmaceutical industry to upend its research priorities. Big Pharma companies are focusing on vaccine development and a slew of biotechs are testing compounds, previously intended for a wide range of indications, as potential COVID-19 treatments. billion merger in the digital health sector.
80 
Let's personalize your content